A statistical consideration on the evaluation of biomarkers

6^th International Conference on Biomarkers & Clinical Research

August 31-September 02, 2015 Toronto, Canada

Laura Gillis

BioStat Solutions, Inc., USA

Posters-Accepted Abstracts: J Mol Biomark Diagn

Abstract :

As the use of multiple types of biomarkers in companion diagnostics continues to grow, evaluation and validation becomes more critical and often more complicated. While DNA biomarkers are stable over time, proteomic biomarkers can change over time depending on disease progression. Epidemiological variables, such as age, often provide additional predictive capability. Combining these biomarkers can lead to better diagnostics, but statistical analysis becomes more complex. This presentation will present techniques that have proven successful in the evaluation of diverse biomarkers for disease and drug response.

Biography :

Email: lbg@biostatsolutions.com